INTRODUCTION
Movement disorders can arise within the context of toxic exposures. There is wide literature linking manganese to the development of parkinsonism and methylmercury to cerebellar toxicity. The best-known example of the connection between toxic exposures and movement disorders occurred in the early 1980s, when an analogue of meperidine intended to emulate the effects of heroin was synthesized by basement chemists without knowledge that one of its byproducts, 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP), would trigger severe nonprogressive parkinsonism among its users.
1 MPTP is converted by monoamine oxidase to methyl-phenylpyridinium ion, a neurotoxin that directly targets nigral dopaminergic neurons and has since become a widely used animal model of Parkinson's disease. An earlier toxin, the pesticide rotenone, also demonstrated nigral neurotoxicity by affecting the complex I component of mitochondrial respiration. However, MPTP has virtually disappeared as a source of clinical toxicity and studies have yet to defi nitely demonstrate that pesticide exposure is a risk for later development of Parkinson's disease.
Rather than an epidemiological focus, this chapter intends to provide a symptom-oriented approach to the potential toxic origin of movement disorders when these can be clearly demonstrated to result from such exposure. We do not, therefore, discuss the increased risks of parkinsonism among rural workers exposed to well water and pesticides, draw attention to the putative neuroprotective effects of smoking, or review the confl icting literature on the contribution of dental amalgams, if any, to the background population exposure to elemental mercury. Indeed, most clinically relevant knowledge regarding abnormalities of movement resulting from toxic exposures is contained in case reports and small case series rather than populationbased studies.
A case study chosen for its relevance introduces each category of abnormal movement. Each of these and their causative exposures are summarized in Table 1 , which is referenced throughout this chapter. Exposures of high relevance for clinicians, appropriately marked in Table 1 , are expanded upon in the text. Table 2 focuses on the most common source for which a toxic movement disorders may be evaluated in the emergency room: iatrogenic acute dystonic reactions. 
